Il mercato globale degli emostati fluidi è stato valutato 899,51 milioni di dollari nel 2021; si prevede che crescerà a un CAGR del 6,9% dal 2022 al 2028.
Gli emostatici fluidi hanno una consistenza fluida e contengono una matrice di gelatina suina o bovina. Può aggiungere trombina topica. Gli emostatici fluidi sono utili quando è necessaria un'applicazione su una superficie difficile da raggiungere o in un campo umido. Il prodotto può essere utilizzato per tutte le procedure chirurgiche, eccetto quelle oftalmiche.
Il mercato globale degli emostati fluidi è segmentato in materiale, prodotto, applicazione, utente finale e area geografica. Per geografia, il mercato globale degli emostati fluidi è ampiamente segmentato in Nord America, Europa, Asia Pacifico, Medio Oriente e Asia. Africa e Sud & America Centrale. Questo rapporto offre approfondimenti e analisi approfondite del mercato, enfatizzando parametri quali tendenze e dinamiche del mercato e l'analisi competitiva dei principali attori del mercato a livello globale.
Approfondimenti strategici
Regioni redditizie per il mercato globale degli emostati fluidi
Approfondimenti di mercato
Popolazione geriatrica in aumento
La popolazione geriatrica richiede interventi chirurgici poiché gli anziani sono considerati vulnerabili e particolarmente sensibile allo stress di traumi, interventi chirurgici e anestesia, con conseguente elevata adozione di emostatici fluidi. L’Europa ha la più grande popolazione che invecchia, a causa dell’improvviso calo dei tassi di mortalità dovuto ai progressi della medicina e al miglioramento degli standard di vita. Secondo il rapporto delle Nazioni Unite (ONU), la Cina ha la più grande popolazione anziana del mondo, che ammonta a 166 milioni (11,9% della popolazione del paese). Secondo le statistiche rivelate dall'Agenzia Anadolu, la popolazione che invecchia in Giappone è di 35,58 milioni. Inoltre, secondo il rapporto dell’Unione Europea (UE), un gran numero di anziani (65 anni e oltre) è morto a causa di cadute, di cui il 58% è stato segnalato al pronto soccorso (ED) nel 2020. L’Associazione della sanità pubblica dell’Unione europea ( Il rapporto EUPHA) afferma che le cadute tra la popolazione geriatrica sono una parte inevitabile dell’invecchiamento. Si prevede che la popolazione anziana (65 anni e oltre) nei paesi europei aumenterà fino al 60% entro il 2050, e si prevede che le cadute aumenteranno fino a quasi 60.000 entro il 2050. Inoltre, esiste un'enorme variazione nei tassi di mortalità legati alle cadute in Europa. . Ungheria e Croazia riportano più di 100 decessi ogni 100.000 anziani, mentre Lussemburgo, Estonia e Bulgaria riportano meno di 10 decessi ogni 100.000 anziani. Tali fattori aumentano il numero di procedure chirurgiche, spingendo in definitiva all'adozione di emostatici fluidi.
L'Organizzazione Mondiale della Sanità (OMS) afferma che, in passato, le lesioni non intenzionali erano classificate come la quarta causa più comune di mortalità tra la popolazione che invecchia in Cina dopo malattie cardiovascolari, cancro e malattie respiratorie. L’invecchiamento della popolazione è in aumento in Cina e in altri paesi a causa dell’aumento dell’aspettativa di vita e dei bassi tassi di fertilità. Inoltre, le cadute sono la principale causa di morti non intenzionali tra la popolazione che invecchia in Cina. Il rapporto dell’Ufficio nazionale di statistica cinese afferma che, nel 2018, la Cina contava circa 249 milioni di cittadini di età pari o superiore a 60 anni, pari a quasi il 17,9% della popolazione. Tra questi, circa 167 milioni di individui hanno 65 anni e più, pari all’11,9% della popolazione totale. Pertanto, l'aumento dell'invecchiamento della popolazione spinge il volume delle procedure chirurgiche, alimentando in ultima analisi la crescita del mercato globale degli emostatici fluidi.
Approfondimenti sui materiali
Sulla base del materiale, gli emostatici fluidi globali sono biforcati in gelatina bovina e gelatina suina. Il segmento della gelatina bovina deteneva una quota di mercato maggiore nel 2021. Inoltre, si prevede che lo stesso segmento registrerà un CAGR più elevato del 7,1% durante il periodo di previsione.
Mercato globale degli emostati fluidi, per materiale: 2021 e 2028
Approfondimenti sul prodotto
In base al prodotto, il mercato globale degli emostatici fluidi è segmentato in emostatici attivi, emostatici passivi ed emostatici combinati. Il segmento degli emostati combinati ha detenuto la quota di mercato maggiore nel 2021. Inoltre, si prevede che lo stesso segmento registrerà il CAGR più elevato, pari al 7,3%, durante il periodo di previsione.
Application Insights
In termini di applicazione, il mercato globale degli emostatici fluidi è segmentato in chirurgia generale, chirurgia cardiaca, chirurgia vascolare, chirurgia ortopedica, neuro & chirurgia della colonna vertebrale e altri. Il segmento della chirurgia generale ha detenuto la quota di mercato maggiore nel 2021. Inoltre, si prevede che lo stesso segmento registrerà il CAGR più elevato, pari al 7,9% durante il periodo di previsione.
Insight per l'utente finale
In base all'utente finale, il mercato globale degli emostati fluidi è segmentato in ospedali e cliniche, centri di chirurgia ambulatoriale e altri. Gli ospedali & Il segmento delle cliniche ha detenuto la quota di mercato maggiore nel 2021. Tuttavia, si prevede che il segmento dei centri di chirurgia ambulatoriale registrerà il CAGR più elevato, pari al 7,8% durante il periodo di previsione.
Sviluppi organici come il lancio e le approvazioni di prodotti sono ampiamente adottati strategie delle aziende nel mercato globale degli emostati fluidi. Di seguito sono elencati alcuni dei recenti sviluppi chiave del mercato:
- Nell'aprile 2019, Baxter International ha annunciato di aver ricevuto l'approvazione dalla Food and Drug Administration (FDA) statunitense per una preparazione più rapida del suo principale prodotto emostatico, Floseal Hemostatic Matrix, alla conferenza chirurgica globale ed all'Expo dell'Association of periOperative Registered Nurses (AORN) del 2019. Questa prossima generazione di Floseal ha il 20% in meno di componenti e passaggi da preparare, rendendo più facile e veloce per gli infermieri di sala operatoria (OR) far arrivare Floseal nelle mani dei chirurghi per aiutare a fermare l'emorragia durante le procedure.
- A giugno Nel 2019, Johnson e Johnson Ethicon hanno ottenuto l'autorizzazione della FDA per i dispositivi di spruzzatura airless per fornire il sigillante a base di fibrina Grifols per arrestare il sanguinamento chirurgico. Il sigillante alla fibrina Vistaseal è stato il primo prodotto introdotto da Grifols nell'ambito della partnership globale con Johnson & Johnson e Ethicon.
Profili aziendali
- Baxter International Inc
- Teleflex Incorporated
- Ethicon (Johnson & ; Johnson)
- Biom'up
- Pfizer Inc.
- Tecnologia medica a matrice 3-D
- Aegis Lifesciences < /ul>
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
This text is related
to segments covered.
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
This text is related
to country scope.
Frequently Asked Questions
The global flowable hemostats based on regions is segmented into North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America. In 2021, the North American area held the largest market share. However, the Asia Pacific region is estimated to grow at the fastest CAGR of 7.0% during the forecast period
The global flowable hemostats based on the material is bifurcated into bovine gelatin and porcine gelatin. Bovine gelatin is likely to hold the largest market share in 2021. Moreover, the same segment is anticipated to register the highest CAGR of 7.1% during the forecast period
Shortage of skilled professionals and poor reimbursement policies are expected to restrict the flowable hemostats growth during the forecast period.
The flowable hemostats majorly consist of the players, such as Baxter International Inc; Teleflex Incorporated; Johnson & Johnson; Biom'up; Pfizer Inc.; Aegis Lifesciences; 3-D Matrix Medical Technology; among others.
Flowable hemostats have flowable consistency and contain a porcine or bovine gelatin matrix. It may add topical thrombin. When an application is needed on a difficult-reach surface or in a wet field flowable hemostats are helpful. The product can be used for all surgical procedures except ophthalmic.
The factors driving the growth of flowable hemostats are the increasing number of injuries and surgical procedures, and the rising geriatric population.
The List of Companies - Flowable Hemostats Market
- Baxter International Inc
- Teleflex Incorporated
- Johnson & Johnson
- Biom'up
- Pfizer Inc.
- Aegis Lifesciences
- 3-D Matrix Medical Technology.
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published and advised several client across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organization are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Related Reports
Sep 2022
Digital PCR (dPCR) Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology [Droplet Digital PCR (ddPCR) and BEAMing Digital PCR], Component (Instruments, Reagents and Consumables, and Software and Services), Application (Clinical, Research, and Forensic), End User (Hospitals and Diagnostic Centers, Pharmaceutical and Biotechnology Companies, Research Laboratories and Academic Institutes, Forensic Laboratories, and Clinical Research Organization), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2022
Colonoscopes Market
Forecast to 2028 - COVID-19 Impact and Global Analysis By Product Type (Fiber Optic Colonoscopy Devices, Video Colonoscopy Devices); Application (Colorectal Cancer, Lynch Syndrome, Ulcerative Colitis, Crohn's Disease, Polyp); End User (Hospitals, Ambulatory Surgery Center, Others), and Geography
Sep 2022
Noninvasive Fat Reduction Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technology (Cryolipolysis, Laser Lipolysis, Ultrasound, and Others), End User (Hospitals, Dermatology Clinics & Cosmetic Clinics, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2022
Medical Ultrasound Flow Meter Market
Size and Forecast (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Implementation Type (Clamp-On, Inline, and Others), Technology (Doppler, Transit Time, and Hybrid), Application (Heart and Lung Machines, Extracorporeal Membrane Oxygenation, Perfusion, Organ Transportation Systems, and Others), End User (Hospitals and Clinics, Ambulatory Surgical Centers, Research Laboratories, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2022
Rapid Test Kits Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Rapid Antigen Testing, Rapid Antibody Testing, and Others), Product (Over-the-Counter Rapid Testing Kit and Professional Rapid Testing Kit), Technology (Lateral Flow Assay, Solid Phase, Agglutination, Immunospot Assay, and Cellular Component-Based), Application (Blood Glucose Testing, Infectious Disease Testing, Pregnancy and Fertility, Cardiometabolic Testing, and Others), End User (Hospital and Clinics, Home Care, Diagnostics Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2022
Osteoarthritis Therapy Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Therapy Type [Transcutaneous Electrical Nerve Stimulation (TENS), Occupational Therapy, Physical Therapy, Platelet-Rich Plasma Therapy and Stromal Vascular Fraction, Prolotherapy, and Others], Disease Indication (Knee Osteoarthritis, Spine Osteoarthritis, Foot and Ankle Osteoarthritis, Shoulder Osteoarthritis, Hand Osteoarthritis, and Others), End User (Hospitals & Clinics, Specialty Clinics, Ambulatory Surgical Centers, Homecare, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2022
Bariatric Surgeries Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Type [Adjustable Gastric Bands (AGB), Sleeve Gastrectomy, Gastric Bypass, Biliopancreatic Diversion with Duodenal Switch (BPD-DS), and Others], End User (Hospitals and Ambulatory Surgical Centers), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Sep 2022
Post-Acute Care Market
Size and Forecasts (2020 - 2030), Global and Regional Share, Trends, and Growth Opportunity Analysis Report Coverage: By Service Type (Skilled Nursing Facilities, Inpatient Rehabilitation Facilities, Long-Term Care Hospitals, Home Health Agency, and Others), Age (Elderly, Adult, and Others), Disease Conditions (Amputations, Wound Management, Brain Injury and Spinal Cord Injury, Neurological Disorders, and Others), and Geography